These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 8578480
21. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
22. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. Musial J, Swadzba J, Motyl A, Iwaniec T. J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190 [Abstract] [Full Text] [Related]
23. [Lupus anticoagulant and antiphospholipid antibody values in a family with systemic lupus erythematosus]. Alper G, Tavmergen EN, Ozsan H, Tavmergen E, Gümüsdis G, Onat T, Erlacin E. Zentralbl Gynakol; 1992 Apr; 114(10):509-12. PubMed ID: 1414067 [Abstract] [Full Text] [Related]
24. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies. Berard M, Boffa MC, Karmochkine M, Aillaud MF, Juhan-Vague I, Francès C, Cacoub P, Piette JC, Harlé JR. J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579 [Abstract] [Full Text] [Related]
25. [Laboratory diagnosis of lupus anticoagulant]. Swadźba J, Musiał J, Jankowski M, Bednarczyk M, Dyczek A, Szczeklik A. Pol Merkur Lekarski; 1996 Nov; 1(5):359-62. PubMed ID: 9273219 [Abstract] [Full Text] [Related]
26. Diagnostic methodologies for circulating anticoagulants. Exner T. Thromb Haemost; 1995 Jul; 74(1):338-44. PubMed ID: 8578481 [Abstract] [Full Text] [Related]
27. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Della Valle P, Crippa L, Garlando AM, Pattarini E, Safa O, Viganò D'Angelo S, D'Angelo A. Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206 [Abstract] [Full Text] [Related]
28. [Antiphospholipid thrombosis syndrome and acquired activated protein C resistance]. Wu J, Zhou Z, Li X, Li X, Chen Y, Wang G, Xu X, Wang Z. Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):122-4. PubMed ID: 11876968 [Abstract] [Full Text] [Related]
29. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome]. Swadźba J, Musiał J, Jankowski M, Grzywacz M, Szczeklik A. Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202 [Abstract] [Full Text] [Related]
34. [Antiphospholipid sydrome--recurrent thrombosis and foetal loss due to antiphospholipid antibodies]. Elezović I, Matijević-Aleksić N, Rolović Z. Srp Arh Celok Lek; 1994 Nov; 122(5-6):179-81. PubMed ID: 17977423 [Abstract] [Full Text] [Related]
35. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay. Gardiner C, Cohen H, Jenkins A, Machin SJ, Mackie IJ. Blood Coagul Fibrinolysis; 2006 Sep; 17(6):477-83. PubMed ID: 16905952 [Abstract] [Full Text] [Related]
39. Antiphospholipid antibodies in children without and in adults with and without thrombophilia. Siemens HJ, Gutsche S, Brückner S, Bucsky P, Katus HA. Thromb Res; 2000 May 15; 98(4):241-7. PubMed ID: 10822070 [Abstract] [Full Text] [Related]
40. Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory. Mader R, Ziporen L, Mader R, Neumann L, Buskila D. Clin Rheumatol; 2002 Sep 15; 21(5):386-90. PubMed ID: 12223987 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]